UNIGE document Scientific Article
previous document  unige:46930  next document
add to browser collection

Caffeine therapy for apnea of prematurity

Schmidt, Barbara
Roberts, Robin S
Davis, Peter
Doyle, Lex W
Barrington, Keith J
Ohlsson, Arne
Solimano, Alfonso
Tin, Win
show hidden authors show all authors [1 - 9]
Published in The New England journal of medicine. 2006, vol. 354, no. 20, p. 2112-21
Abstract Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation during the first seven days of therapy. It is uncertain whether methylxanthines have other short- and long-term benefits or risks in infants with very low birth weight.
Keywords Apnea/drug therapy/therapyBronchopulmonary Dysplasia/prevention & controlCaffeine/pharmacology/therapeutic useCentral Nervous System Stimulants/pharmacology/therapeutic useCombined Modality TherapyFemaleHumansInfant, NewbornInfant, PrematureInfant, Premature, Diseases/drug therapyInfant, Very Low Birth WeightLogistic ModelsMaleOxygen Inhalation TherapyRespiration, ArtificialWeight Gain/drug effects
PMID: 16707748
Full text
Article (Published version) (177 Kb) - public document Free access
Research group Réanimation néonatale en salle d'accouchement (696)
(ISO format)
SCHMIDT, Barbara et al. Caffeine therapy for apnea of prematurity. In: The New England journal of medicine, 2006, vol. 354, n° 20, p. 2112-21. doi: 10.1056/NEJMoa054065 https://archive-ouverte.unige.ch/unige:46930

968 hits



Deposited on : 2015-02-19

Export document
Format :
Citation style :